
89bio, Inc. — Investor Relations & Filings
89bio, Inc. is a clinical-stage biopharmaceutical company that develops therapies for liver and cardiometabolic diseases. The company's lead product candidate, pegozafermin, is a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21). It is being developed for the treatment of non-alcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). The company focuses on creating innovative and potentially best-in-class treatments to address unmet medical needs in its target patient populations.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| Regulatory Filings 2025 | 2025-11-20 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-13 | English | |
| 15-12G | 2025-11-10 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 31702524 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
|
2025
14 filings
| |||||
| 13197454 | Regulatory Filings 2025 | 2025-11-20 | English | ||
| 13197455 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13197456 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13197457 | Major Shareholding Notification 2025 | 2025-11-13 | English | ||
| 13197458 | 15-12G | 2025-11-10 | English | ||
| 13197459 | Major Shareholding Notification 2025 | 2025-11-03 | English | ||
| 13197460 | Director's Dealing 2025 | 2025-11-03 | English | ||
| 13197461 | Major Shareholding Notification 2025 | 2025-10-31 | English | ||
| 13197462 | 4 | 2025-10-30 | English | ||
| 13197463 | 4 | 2025-10-30 | English | ||
| 13197464 | 4 | 2025-10-30 | English | ||
| 13197465 | 4 | 2025-10-30 | English | ||
| 13197466 | 4 | 2025-10-30 | English | ||
| 13197467 | 4 | 2025-10-30 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Bajaj Healthcare Limited
Develops and manufactures APIs, intermediates, and finished…
|
BAJAJHCARE | IN | Manufacturing |
|
Bal Pharma Ltd.
Develops and manufactures APIs and finished formulations fo…
|
BALPHARMA | IN | Manufacturing |
|
Barinthus Biotherapeutics plc.
Clinical-stage biopharma developing immunotherapies that gu…
|
BRNS | GB | Manufacturing |
|
Basilea Pharmaceutica AG
Biopharmaceutical firm developing drugs for severe bacteria…
|
BSLN | CH | Manufacturing |
|
BASKHANBIOPharma Inc.
Offers pharmaceuticals, medical devices, and health product…
|
354390 | KR | Manufacturing |
|
Bausch Health Companies Inc.
Develops, manufactures, and markets pharmaceuticals, OTC pr…
|
BHC | CA | Manufacturing |
|
Bausch & Lomb Corp
Global eye health company offering vision care, pharmaceuti…
|
BLCO | CA | Manufacturing |
|
Bavarian Nordic
Biotechnology company developing and commercializing vaccin…
|
BAVA | DK | Manufacturing |
|
BAXTER INTERNATIONAL INC
Provides essential products for renal care, hospital, and s…
|
BAX | US | Manufacturing |
|
Bayer AG
A global life science company with core competencies in hea…
|
BAY | DE | Manufacturing |
89bio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31613/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31613 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31613 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31613 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31613}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 89bio, Inc. (id: 31613)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.